ConductScience.org, home

Paper39199337

Novel Therapeutic Horizons: SNCA Targeting in Parkinson's Disease.

Caramiello AM and 1 other. Biomolecules, 2024. Cited by 18 papers, by iCite.

Cite this record

ConductScience Library. Novel Therapeutic Horizons: SNCA Targeting in Parkinson's Disease. Papers, record 39199337. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39199337

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Novel Therapeutic Horizons: SNCA Targeting in Parkinson's Disease.
PubMed
Journal
Biomolecules
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
18
iCite
Relative citation ratio, by iCite
2.99, provisional
iCite
Revised in PubMed
2026-04-10
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Caramiello AMAlessio Mariahttps://orcid.org/0000-0002-8887-4276
2Pirota VValentinahttps://orcid.org/0000-0002-6683-1726

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
alpha-SynucleinMajor topic
Parkinson DiseaseMajor topic
Humans
Animals
Oligonucleotides, Antisense
RNA, Small Interfering
Dopaminergic Neurons

Source PubMed

Download CSV of topics

References81

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112489851Antisense oligonucleotides: basic concepts and mechanisms.Mol Cancer Ther2002https://conductscience.org/library/papers/12489851PubMed
227735097Copper-Aβ Peptides and Oxidation of Catecholic Substrates: Reactivity and Endogenous Peptide Damage.Chemistry2016https://conductscience.org/library/papers/27735097PubMed
328375731CRISPR-Cas9 Structures and Mechanisms.Annu Rev Biophys2017https://conductscience.org/library/papers/28375731PubMed
425495987miRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents.Future Med Chem2014https://conductscience.org/library/papers/25495987PubMed
530906671Translational inhibition of α-synuclein by Posiphen normalizes distal colon motility in transgenic Parkinson mice.Am J Neurodegener Dis2019https://conductscience.org/library/papers/30906671PubMed
621221670The alpha-synuclein 5'untranslated region targeted translation blockers: anti-alpha synuclein efficacy of cardiac glycosides and Posiphen.J Neural Transm (Vienna)2011https://conductscience.org/library/papers/21221670PubMed
729192260Antisense oligonucleotides: the next frontier for treatment of neurological disorders.Nat Rev Neurol2018https://conductscience.org/library/papers/29192260PubMed
829669594miRNAs regulate immune response and signaling during hepatitis C virus infection.Eur J Med Res2018https://conductscience.org/library/papers/29669594PubMed
932954426The mechanistic role of alpha-synuclein in the nucleus: impaired nuclear function caused by familial Parkinson's disease SNCA mutations.Hum Mol Genet2020https://conductscience.org/library/papers/32954426PubMed
1030658149Long-term RNAi knockdown of α-synuclein in the adult rat substantia nigra without neurodegeneration.Neurobiol Dis2019https://conductscience.org/library/papers/30658149PubMed
1131518552Advances and challenges in studying noncoding RNA regulation of drug metabolism and development of RNA therapeutics.Biochem Pharmacol2019https://conductscience.org/library/papers/31518552PubMed
1229243000RNA interference-based therapy and its delivery systems.Cancer Metastasis Rev2018https://conductscience.org/library/papers/29243000PubMed
1327248657Constitutive translation of human α-synuclein is mediated by the 5'-untranslated region.Open Biol2016https://conductscience.org/library/papers/27248657PubMed
1423686823Antisense oligonucleotides: treating neurodegeneration at the level of RNA.Neurotherapeutics2013https://conductscience.org/library/papers/23686823PubMed
1538181056Decreasing the intrinsically disordered protein α-synuclein levels by targeting its structured mRNA with a ribonuclease-targeting chimera.Proc Natl Acad Sci U S A2024https://conductscience.org/library/papers/38181056PubMed
1617603039Cell systems and the toxic mechanism(s) of alpha-synuclein.Exp Neurol2008https://conductscience.org/library/papers/17603039PubMed
1727397479Pharmacomodulation of microRNA Expression in Neurocognitive Diseases: Obstacles and Future Opportunities.Curr Neuropharmacol2017https://conductscience.org/library/papers/27397479PubMed
1827097021Inforna 2.0: A Platform for the Sequence-Based Design of Small Molecules Targeting Structured RNAs.ACS Chem Biol2016https://conductscience.org/library/papers/27097021PubMed
1931866823Targeting Alpha-Synuclein as a Therapy for Parkinson's Disease.Front Mol Neurosci2019https://conductscience.org/library/papers/31866823PubMed
2020551914In vivo RNAi-mediated alpha-synuclein silencing induces nigrostriatal degeneration.Mol Ther2010https://conductscience.org/library/papers/20551914PubMed

See all 81 referencesDownload CSV of references

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.

PMIDTitleJournalYearIn PapersSource
42378631Colorectal Cancer Liver Metastasis-Associated Ferroptosis-Related Genes Modulate Lipid Peroxidation in Colorectal Cancer Cells.Mol Carcinog2026https://conductscience.org/library/papers/42378631PubMed
42064924LIFETIME JEM-DERIVED OCCUPATIONAL EXPOSURE BURDEN AND ODDS OF PARKINSON'S DISEASE AND PARKINSONISM IN A MATCHED CASE-CONTROL STUDY.medRxiv2026https://conductscience.org/library/papers/42064924PubMed
41929945Identification of potential short-chain fatty acid biomarkers in Alzheimer's disease through bioinformatics analysis.J Alzheimers Dis Rep2026https://conductscience.org/library/papers/41929945PubMed
41596551Identification of KHS-101 as a Transcription Factor EB Activator to Promote α-Synuclein Degradation.Int J Mol Sci2026https://conductscience.org/library/papers/41596551PubMed
41540050Early retinal synaptic dysfunction and proteomic remodeling precede neurodegeneration in a Parkinson's disease model.NPJ Parkinsons Dis2026https://conductscience.org/library/papers/41540050PubMed
41484831Antisense Oligonucleotide Therapeutics Targeting Age-Related Diseases.BioDrugs2026https://conductscience.org/library/papers/41484831PubMed
41278771Targeted α-Synuclein mRNA Degradation by PMO-Based RNA-Degrading Chimeras.bioRxiv2025https://conductscience.org/library/papers/41278771PubMed
41127543Application of biomimetic approaches in the treatment of neurological disorders.Mater Today Bio2025https://conductscience.org/library/papers/41127543PubMed
41082301Progress in Disease-Modifying Therapies for Parkinson's Disease.Aging Dis2025https://conductscience.org/library/papers/41082301PubMed
41023705In vivo validation of novel non-invasive PHP.eB AAVs as a potential therapeutic approach for alpha-synucleinopathies.Acta Neuropathol Commun2025https://conductscience.org/library/papers/41023705PubMed
40815569Alpha-synuclein abundance and localization are regulated by the RNA-binding protein PUMILIO1.Cell Rep2025https://conductscience.org/library/papers/40815569PubMed
40613913A review on current theories and potential therapies for prion diseases.Mol Biol Rep2025https://conductscience.org/library/papers/40613913PubMed
40589152Gaps in the Parkinson's disease therapeutic clinical pipeline: A focus on approaches targeting disease pathobiology.J Parkinsons Dis2026https://conductscience.org/library/papers/40589152PubMed
39997657Therapeutic Role of Heterocyclic Compounds in Neurodegenerative Diseases: Insights from Alzheimer's and Parkinson's Diseases.Neurol Int2025https://conductscience.org/library/papers/39997657PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
SNCA6622PubTator's text mininghttps://conductscience.org/library/genes/6622

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39199337

GET https://conductscience.org/api/papers/v1/39199337/references?page=2